EPAD opens six new study sites

The European Prevention of Alzheimer’s Dementia Consortium (EPAD) is recruiting research participants at six new sites, bringing the total to ten centres in six European countries. People in France, the Netherlands, Spain, Sweden, Switzerland and UK can now take part in the study, which aims to develop tests to identify early signs of Alzheimer’s disease…

APM Awards 2017

The Association for Project Management (APM) was formed in 1972, with the mission to “Inspire communities to deliver meaningful change for societal benefit by advancing the art, science, theory and practice of project management”. This award-winning association has over 23,000 individual and 570 corporate members making it the largest professional body of its kind in…

Members of the EPAD communication team meet to update the project’s communication strategy

On 20 November, members of the EPAD WP6 communication team held a one day meeting in Amsterdam to update the communication plan for the final two years of the project. The team discussed the updated project’s communication strategy, focus plan and activities for 2018-2019. The participants started to review the communication activities undertaken from 2015-2017.…

Interview with Lea ter Meulen

What is your current role in EPAD? I wear two hats within EPAD. Firstly I work for WP3, which is led by Pieter Jelle Visser at VUmc and Gerald Luscan at Pfizer. Together with a great team of colleagues, I’m involved in the process of informing new cohorts and getting them connected to the Registry.…

Interview with Gary Romano

What is your current role in EPAD? I am a member of the Executive committee, the CDEx clinical Mitterrand and balancing committee.   What did you do prior to joining EPAD? I have been working in neuroscience drug development for nearly 16 years, at Merck and at Janssen.      Tell us a bit about…

EPAD organises a cross-IMI Disease Modelling Workshop

On 16-18 October, the European Prevention of Alzheimer’s dementia (EPAD) project organised its first IMI-AD Platform Disease Modelling Workshop in Edinburgh, UK. The aim of the meeting was to bring together the modelling community within IMI funded projects to facilitate and encourage interactions between the overlapping communities. On the first day, the chair of the…

EPAD invited to speak at Alzheimer Europe Conference

A great occasion to get to know more on three Alzheimer’s Disease IMI (Innovative Medicines Initiative) projects, was at the 27th Alzheimer Europe Conference (#27AEC), held in Berlin from 2-4 October. At a symposium convened by Eli Lilly, entitled: “Engaging with patient organisations within IMI consortia to inform quality, relevance and value in Alzheimer’s research…